Long-term follow-up of patients in four prospective studies of the German Breast Cancer Study Group (GBSG): A summary of key results

Onkologie

Volumn 25, Issue 2, 2002, Pages 143-150

  Schmoor, C ^a,b   Olschewski, M ^a   Sauerbrei, W ^a   Schumacher, M ^a  

^a Institut für Medizinische Biometrie und Medizinische Informatik   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Breast cancer; Clinical trials; Long term follow up; Prognostic factors; Treatment

Indexed keywords

CYCLOPHOSPHAMIDE; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; PROGESTERONE RECEPTOR; TAMOXIFEN;

ARTICLE; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; FOLLOW UP; HORMONAL THERAPY; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MULTIMODALITY CANCER THERAPY; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL RATE; TUMOR VOLUME;

ADULT; AGED; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; LYMPHATIC METASTASIS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; MULTICENTER STUDIES; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS; SURVIVAL RATE;

EID: 0036249668     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000055224     Document Type: Article

References (28)

1. Randomized and non-randomized patients in clinical trials: Experiences with Comprehensive Cohort Studies
2. Eight-year results of a prospective non-randomised study on therapy of small breast cancer
3. Validation of existing and development of new prognostic classification schemes in node negative breast cancer
4. Histological grading and prognosis in breast cancer
5. Randomized 2x2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients
6. Nonparametric estimation from incomplete observation
7. Regression models and life table (with discussion)
8. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Part I
9. Part II
10. Adjusted survival curve estimation using covariates
11. Randomized 2×2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients: An update based on 10 years' follow-up
12. Role of isolated locoregional recurrence of breast cancer: Results of four prospective studies
13. Randomized trial on the effect of radiotherapy in addition to 6 cycles of CMF in node positive breast cancer patients
14. Comprehensive cohort study: An alternative to randomized consent design in a breast preservation trial
15. Long-term prognosis of breast cancer patients with 10 or more positive lymph nodes treated with CMF
16. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials
17. Tamoxifen for early breast cancer: An overview of the randomised trials
18. Polychemotherapy for early breast cancer: An overview of the randomised trials
19. The effect of oral contraceptive use on the prognosis of node positive breast cancer patients
20. Modelling the effects of standard prognostic factors in node-positive breast cancer
21. The prognostic effect of histological tumor grade in node-negative breast cancer patients
22. Adjuvant systemic therapy in women with early-stage breast cancer at high risk for relapse
23. Methodological arguments for the necessity of randomized trials in high-dose chemotherapy for breast cancer
24. Critique of the high-dose chemotherapy studies in breast cancer: A positive look at the data
25. High-dose chemotherapy as adjuvant treatment for breast cancer - Some statistical arguments
26. A note on estimating local recurrence rates in clinical trials on the treatment of breast cancer
27. On problems related to subgroup analyses in clinical trials
28. On the problem of using 'optimal' cutpoints in the assessment of quantitative prognostic factors